Welcome to the Peptide Therapeutics FoundationThe Peptide Therapeutics Foundation is a not-for-profit 501C(3), established in 2008 to promote research and development of peptide therapeutics. The Foundation and Symposium are supported by the following corporate sponsors: ChemPartner, Ferring Research Institute Inc., Novo Nordisk, Medimmune/ Astra Zeneca, the PolyPeptide Group, Zealand Pharma, and Zydus Cadila. To learn more about our corporate sponsors and board members click here. Click here for an overview of the peptide therapeutic landscape, including historical perspectives, molecular characteristics, regulatory benchmarks, and a therapeutic area breakdown. |
![]() Peptide Therapeutic Foundation announces the recipients of the Ferring Research Institute Innovation Grants Program for 2018: Fiona Cousins – Hudson Institute of Medical Research, Monash University Laurent Derré – University Hospital of Lausanne (CHUV) Marta Dueñas – Fundación para la Investigación Hospital 12 de Octubre Tracey Edgell – Hudson Institute of Medical Research, Monash University Pradipta Ghosh – University of California, San Diego Emmet Hirsch – NorthShore University HealthSystem Sarah Marshall – Monash University Harmeet Malhi – Mayo Clinic Hiroshi Miyamoto – University of Rochester Meet the 2017 Recipients: ![]() October 25-26, 2018 The 13th Annual Peptide The Salk Institute |
![]() Click here to learn more about The Peptide Therapeutics Foundation or our Annual Peptide Therapeutics Symposium. |